Skip to content

Advertisement

  • Research
  • Open Access

Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro

Lipids in Health and Disease201110:159

https://doi.org/10.1186/1476-511X-10-159

©  Das and Madhavi; licensee BioMed Central Ltd. 2011

  • Received: 31 August 2011
  • Accepted: 14 September 2011
  • Published:

Abstract

Previous studies showed that γ-linolenic acid (GLA, 18: 3 ω-6), arachidonic acid (AA, 20:4 ω -6), eicosapentaenoic acid (EPA, 20: 5 ω -3) and docosahexaenoic acid (DHA, 22:6 ω -3) have selective tumoricidal action. In the present study, it was observed that dihomo-gamma-linolenic acid (DGLA) and AA, EPA and DHA have cytotoxic action on both vincristine-sensitive (KB-3-1) and resistant (KB-ChR-8-5) cancer cells in vitro that appeared to be a free-radical dependent process but not due to the formation of prostaglandins, leukotrienes and thromboxanes. Uptake of vincristine and fatty acids was higher while their efflux was lower in KB-3-1 cells compared with KB-ChR-8-5 cells, suggesting that drug resistant cells have an effective efflux pump. GLA, DGLA, AA, EPA and DHA enhanced the uptake and decreased efflux in both drug-sensitive and drug-resistant cells and augmented the susceptibility of tumor cells especially, of drug-resistant cells to the cytotoxic action of vincristine. These results suggest that certain polyunsaturated fatty acids have tumoricidal action and are capable of enhancing the cytotoxic action of anti-cancer drugs specifically, on drug-resistant cells by enhancing drug uptake and reducing its efflux. Thus, polyunsaturated fatty acids either by themselves or in combination with chemotherapeutic drugs have the potential as anti-cancer molecules.

Keywords

  • Polyunsaturated fatty acids
  • essential fatty acids
  • free radicals
  • vincristine
  • lipid peroxidation
  • cancer
  • uptake
  • efflux
  • arachidonic acid
  • eicosapentaenoic acid
  • docosahexaenoic acid
  • gamma-linolenic acid
  • linoleic acid
  • linolenic acid

Introduction

It is desirable to kill tumor cells selectively without harming normal cells. But, currently available drugs and radiation fail to kill only tumor cells and cause significant side effects that are undesirable. Anti-VEGF (vascular endothelial growth factor) and anti-EGF (epidermal growth factor) and other monoclonal antibodies developed for use in cancer do possess some degree of specific action on tumor cells yet are not very effective. In view of this, further studies are needed to identify newer molecules that possess selective tumoricidal property that are less toxic but have predictable actions.

Previously, we and others showed that some polyunsaturated fatty acids (PUFAs) induced apoptosis of tumor cells with little or no cytotoxic action on normal cells under the conditions employed [1–10]. It was observed that of all the fatty acids tested, GLA was the most effective in selectively killing the tumor cells. In a co-culture experiment wherein normal human skin fibroblasts (CCD-41-SK) and human breast cancer cells (ZR-75-1) were grown together in a petri dish and supplemented with GLA, only human breast cancer cells were eliminated without any effect on normal skin fibroblasts [11]. These results reconfirmed that GLA and possibly, other PUFAs under some specific conditions show selective tumoricidal action at least in vitro. GLA and other unsaturated other fatty acids induced apoptosis of tumor cells by enhancing the release of cytochrome c, activating caspase-3, suppressing Akt phosphorylation and modulating p38 MAPK in the phosphorylation of p53 at Ser15, a site which is associated with DNA damage (9, 10). These molecular changes were found to be significantly associated with enhanced degree of lipid peroxidation in the fatty acid supplemented tumor cells (1-5, 9). GLA and other PUFAs were also found to be capable of suppressing the expression of oncogenes ras and Bcl-2 and enhance p53 activity and thus, induce apoptosis of tumor cells [12].

In an extension of these studies, it was noted that cyclo-oxygenase (CO) and lipoxygenase (LO) inhibitors blocked the tumoricidal action of GLA on human cervical carcinoma, HeLa cells; whereas anti-oxidants inhibited cytotoxic action of GLA on human breast cancer, ZR-75-1, cells [1, 2, 4]. Prostaglandins (PGE1, PGE2, PGF2α, PGI2) and LO products of GLA: 13-HPODE and 6-HPODE, inhibited the growth of HeLa cells [2, 4]. LO products were more potent than PGs in inhibiting of HeLa cell growth [4] that was confirmed by the observation that a 9-fold increased formation of hydroxides occurred in HeLa cells treated with GLA. These results suggest that both CO and LO products and free radicals are involved in the tumoricidal action of GLA. A significant increase in the formation of free radicals and lipid peroxides was noted only in tumor cells treated with GLA (GLA > AA > EPA > LA) compared to untreated tumor cells or GLA-treated normal skin fibroblasts [1, 4, 5, 9, 13, 14], suggesting that the involvement of CO and LO products, free radicals and lipid peroxides in the tumoricidal action of GLA and PUFAs varies depending on the cell type that is being tested.

Drug resistance is a major issue in the management of cancer. Hence, methods or strategies to prevent and/or reverse tumor cell dug resistance are needed. Previously, we observed that GLA could kill even drug resistant tumor cells in vitro[15]. GLA augmented the cytotoxic action of anti-cancer drugs cis-platinum and doxorubicin [16]. Studies by Menendez et al[17], Hernandez et al[18], and Rudra et al[19] confirmed that GLA and other unsaturated fatty acids augment tumoricidal actions of anti-cancer drugs and a synergism exists between conventional anti-cancer drugs and GLA. But, it is not clear as to the exact mechanism by which this synergism between anti-cancer drugs and fatty acids occurs. In the present study, we studied the effects of various PUFAs on drug-sensitive and drug-resistant tumor cells, possible potentiation of the tumoricidal action of sub-optimal anti-cancer drugs on drug-resistant cells and possible mechanisms(s) involved in these actions.

Materials and methods

Cells and culture conditions

Human cervical carcinoma cells which are sensitive (KB-3-1) and resistant (KB-ChR-8-5) to the cytotoxic action of vincristine respectively were used for this study. KB-3-1 and KB-ChR-8-5 are HeLa variant cell lines.

These cells were grown and maintained in NUNC culture flasks in bicarbonate buffered DMEM with 10% fetal calf serum and L-glutamine at 37°C in a 5% CO2 humidified incubator. KB-ChR-8-5 cells, which are 4-fold resistant to colchicine, were grown in the continuous presence of colchicine [15, 20–22]. Cells were seeded at 1 × 104 cells/ml/well in 24 well tissue culture plates for various studies. One day after seeding, the medium was removed and fresh medium with/without various fatty acids, and other compound solutions was added depending on the experimental protocol. The fatty acids were initially dissolved in 95% ethanol and the final concentration of ethanol was not more than 0.02% in all control and fatty acid supplemented cultures.

Cell viability studies

KB-3-1 and KB-ChR-8-5 cells treated with various fatty acids and other compounds were also assessed for their viability at the end of various incubation periods. The viability of cells was assessed by using Trypan blue dye exclusion method.

Thymidine incorporation studies

To study the growth of KB-3-1 and KB-ChR-8-5 cells in the presence of various concentrations of different fatty acids and the effect of cyclo-oxygenase (CO) and lipoxygenase (LO) inhibitors, anti-oxidants and calmodulin antagonists, the ability of cells to incorporate radiolabeled thymidine as a function of DNA synthesis was used. One day after seeding, 0.5 μCi of labeled thymidine (specific activity 18, 500 mCi/mmol) was added 6 hours before harvesting the cells. At the end of the incubation period, the cells were washed at least three times with PBS (pH 7.4), detached by trypsinization, extracted for DNA, and counted in a liquid scintillation counter on days 1, 2 and 3 to assess cell growth.

NBT reduction

The superoxide anion (O2 .- ) can reduce nitroblue tetrazolium (NBT) ion to the insoluble formazan. This is a simple, reliable and acceptable method of assaying superoxide anion and possibly, other free radicals [1, 18–21]. KB-3-1 and KB-ChR-8-5 cells grown with or without fatty acids, with or without other compounds for 24, 48 a 72 hours were checked for their ability to reduce NBT by incubation with 0.1% NBT dissolved in phosphate buffered saline (pH 7.4) for 2 hours at the end of each time period. Termination of the assay (final assay volume 0.3 ml) was done by adding 0.6 ml of glacial acetic acid into which the reduced NBT dye was extracted and read at 560 nm as described previously [1, 23–25].

Hydrogen peroxide formation

The amount of H2O2 formed in KB-3-1 and KB-ChR-8-5 cells with and without fatty acid treatment and other compounds was estimated by the horse-radish peroxidase method [26–28].

Lipid peroxidation

The total amount of lipid peroxidation products formed in the cells was estimated using the thiobarbituric acid (TBA) method [29, 30].

Uptake of radiolabeled vincristine

The uptake of radiolabeled vincristine was studied using 3H-vincristine sulfate (specific activity 6.2 Ci mmol-1). To 1 × 104 cells/ml/well, one day after seeding, the medium was replaced with fresh medium along with 50 nm [3H] vincristine was added and incubated for further tile periods. At the end of 1, 2, 4, 6 and 12 hours of addition of vincristine, the cells were washed, detached by trypsinization and counted in a liquid scintillation counter. To study the effect of fatty acids on vincristine uptake, one day after seeding KB-3-1 and KB-ChR-8-5 cells were incubated with different doses of fatty acids ranging from 10 to 40 μg/ml. After 6 hours of addition of fatty acids, 50 nm of [3H] vincristine was added and incubated for further time periods. At the end of 1, 2 and 4 hours of radiolabeled vincristine addition; cells were washed thrice with PBS, detached by trypsinization and counted in a liquid scintillation counter.

All the experiments were performed in quadruplicate and repeated at least twice. Result are expressed as Mean ± SD and analyzed using Student's t test and/or one-was analysis of variance followed by Tukey's Honesty Significant Difference (HSD) test.

Efflux of [3H] vincristine in the presence of fatty acids

1 × 104 cells/ml/well were seeded in 24-well plates. Cells were allowed to attach to plastic overnight and at the end of 24 hours, medium was aspirated and fresh medium added along with fatty acids whose concentrations ranged from 5-40 μg/ml. At the end of 4 hours of fatty acid incubation, 50 nM [3H] vincristine was added and incubated for another 2 hours after which the medium was discarded and cells were washed with PBS. 0.5 ml of phenol red free DMEM was added to the cells and incubated for 1, 2 and 4 hours. At the end of the incubation period, the medium was aspirated and counted in a liquid scintillation counter.

Uptake of radiolabeled fatty acids

The uptake of radiolabeled fatty acids (ALA, AA and EPA) was studied using 14C-labeled ALA, AA and EPA (specific activity 54, 55, 59 mCi/mmol). To 1 × 104 cells/ml/well, one day after seeding, the medium was replaced with fresh medium along with 50 nm [14C] of respective fatty acid was added and incubated for further tile periods. At the end of 6, 12, 24, 28, and 72 hours of addition of fatty acid, the cells were washed, detached by trypsinization and counted in a liquid scintillation counter.

Efflux of [14C] fatty acids by vincristine-sensitive (KB-3-1) and vincristine-resistant (KB-ChR-8-5) cells

1 × 104 cells/ml/well were seeded in 24-well plates. Cells were allowed to attach to plastic overnight and at the end of 24 hours, medium was aspirated and fresh medium added along with labeled fatty acids. At the end of 6, 12, 24, 48, and 72 hours4 hours of labelled fatty acid incubation, the medium was aspirated and counted in a liquid scintillation counter.

Statistics

All the experiments were performed in quadruplicate and repeated at least twice. Result are expressed as Mean ± SD and analyzed using Student's "t" test and/or one-was analysis of variance followed by Tukey's Honesty Significant Difference (HSD) test depending on the experimental protocols.

Results

Effect of various fatty acids on the survival of vincristine-sensitive and resistant tumor cells in vitro

Results shown in Figure 1 clearly indicate that KB-ChR-8-5 cells are resistant to the cytotoxic action of vincristine whereas KB-3-1 cells are more sensitive to its action.
Figure 1
Figure 1

Effect of various concentrations of vincristine on the survival of vincristine sensitive (KB-3-1) and resistant (KB-Ch R -8-5) tumor cells in vitro expressed as percentage of control. All values are Mean ± SD.

The data in Figure 2 shows that DHA, EPA and AA are the most effective of all the fatty acids tested with regard to their cytostatic/toxic effects on KB-3- and KB-ChR-8-5 cells. The cytostatic/cytotoxic effect of various fatty acids tested is further evident from the thymidine incorporation studies given in Figures 3, 4, 5 and 6. These results showed that thymidine incorporation decreases as the dose of fatty acids is increased. The cytostatic/cytotoxic action of fatty acids on KB-3-1 cells in order of potency is as follows: DHA > EPA > GLA = DGLA > AA > LA > ALA. On the other hand, the cytostatic/cytotoxic action of fatty acids on KB-ChR-8-5, the vincristine-resistant cells, in order of potency is as follows: DHA > AA > DGLA = EPA = GLA > LA > ALA. These results indicate that both vincristine-sensitive and resistant cells are almost equal in their sensitivity to the cytotoxic action of various fatty acids tested.
Figure 2
Figure 2

Effect of different doses of n-6 and n-3 fatty acids on the survival of vincristine-sensitive (KB-3-1) and vincristine-resistant (K-B-Ch R -8-5) tumor cells in vitro on day 3 expressed as percentage of control. All values are Mean ± SD.

Figure 3
Figure 3

Effect of different doses of LA and GLA on thymidine uptake by vincristine-sensitive (KB-3-1) and vincristine-resistant (K-B-Ch R -8-5) tumor cells in vitro on days 1-3 expressed as percentage of control. All values are Mean ± SD.

Figure 4
Figure 4

Effect of different doses of DGLA and AA on thymidine uptake by vincristine-sensitive (KB-3-1) and vincristine-resistant (K-B-Ch R -8-5) tumor cells in vitro on days 1-3 expressed as percentage of control. All values are Mean ± SD.

Figure 5
Figure 5

Effect of different doses of ALA and EPA on thymidine uptake by vincristine-sensitive (KB-3-1) and vincristine-resistant (K-B-Ch R -8-5) tumor cells in vitro on days 1-3 expressed as percentage of control. All values are Mean ± SD.

Figure 6
Figure 6

Effect of different doses of DHA on thymidine uptake by vincristine-sensitive (KB-3-1) and vincristine-resistant (K-B-Ch R -8-5) tumor cells in vitro on days 1-3 expressed as percentage of control. All values are Mean ± SD.

Effect of CO, LO inhibitors, anti-oxidants and calmodulin antagonists on the cytotoxic action of polyunsaturated fatty acids

Since polyunsaturated fatty acids (PUFAs) form precursors to various prostaglandins (PGs), leukotrienes (LTs) and thromboxanes (TXs), induce the generation of free radicals and modulate the action of calmodulins, the possibility that the fatty acids tested are able to bring about their cytotoxic action on KB-3-1 cells based on these mechanisms was tested using CO and LO inhibitors, various anti-oxidants and calmodulin antagonists. The results of this study done with GLA and DHA as representative of n-6 and n-3 fatty acids given in Figures 7 and 8 revealed that indomethacin, a CO inhibitor, and NDGA, a LO inhibitor, were ineffective in blocking the cytotoxic action of GLA and DHA.
Figure 7
Figure 7

Effect of various anti-oxidants, cyclo-oxygenase and lipoxygenase inhibitors and calmodulin antagonists on thymidine incorporation in KB-3-1 cells in vitro on day 1, 2 and 3. All values are Mean ± SD.

Figure 8
Figure 8

Effect of various anti-oxidants, cyclo-oxygenase and lipoxygenase inhibitors and calmodulin antagonists on GLA and DHA-induced growth inhibition of KB-3-1 cells in vitro.

It is evident from the results shown in Figure 8 that both indomethacin and NDGA, a CO and LO inhibitors respectively, were ineffective in blocking the cytotoxic action of GLA on KB-3-1 cells in vitro. Both vitamin E and SOD completely blocked the cytotoxic action of GLA on KB-3-1 cells, while synthetic anti-oxidants such as BHA and BHT and calmodulin antagonists: chlorpromazine (CPZ) and trifluoperazine (TFP) were ineffective. On the other hand, both mannitol and catalase were effective in inhibiting the GLA-induced cytotoxicity only by about 40-60%. These results are more evident by day 3.

Similar to the results seen with GLA, even with DHA it is clear from the results shown in Figure 8 that both indomethacin and NDGA, a CO and LO inhibitors respectively, were ineffective in blocking the cytotoxic action of DHA on KB-3-1 cells in vitro. Both vitamin E and SOD completely blocked the cytotoxic action of GLA on KB-3-1 cells, while synthetic anti-oxidants such as BHA and BHT and calmodulin antagonists: chlorpromazine (CPZ) and trifluoperazine (TFP) were ineffective. On the other hand, unlike the results seen with GLA, both mannitol and catalase were as effective as that of vitamin E and SOD in inhibiting the DHA-induced cytotoxicity. These results are more evident on day 3.

Effect of PUFAs on free radical generation by KB-3-1 and KB-ChR-8-5 cells in vitro

Since vitamin E and SOD (superoxide dismutase), an effective anti-oxidant and a superoxide quencher respectively, blocked the cytotoxic action of fatty acids on KB-3-1 and KB-ChR-8-5 cells, and since free radical generation can be modulated by fatty acids, the effect of various n-6 and n-3 fatty acids on superoxide anion and H2O2 generation and the formation of lipid peroxides in these cells was studied. The results shown in Figures 9, 10, 11, 12, 13 and 14 indicate that although all the fatty acids are effective, relatively higher amounts of superoxide and H2O2 generation and formation of lipid peroxides were observed in GLA, AA, EPA and DHA-treated KB-3-1 and KB-ChR-8-5 cells. It is noteworthy that enhanced generation of superoxide anion, H2O2 and lipid peroxides induced by GLA, AA, EPA and DHA corresponded to their cytotoxic action on KB-3-1 and KB- ChR-8-5 cells.
Figure 9
Figure 9

Effect of various n-6 and n-3 fatty acids on the amount of superoxide anion generated in KB-3-1 cells measured as NBT reduction and expressed as μ moles of diformazan formed in vitro. All values are Mean ± SD. * P < 0.05 compared to control.

Figure 10
Figure 10

Effect of various concentrations of different n-6 and n-3 fatty acids on the generation of H 2 O 2 by KB-3-1 cells in vitro. All values are expressed as μ moles of H2O2 formed. All values are Mean ± SD. * P < 0.05 compared to control.

Figure 11
Figure 11

Effect of different doses of n-6 and n-3 fatty acids on the formation of lipid peroxides (expressed as pmoles of MDA-eq formed) in KB-3-1 cells in vitro. All values are Mean ± SD. *P < 0.05 compared to control.

Figure 12
Figure 12

Effect of various n-6 and n-3 fatty acids on the amount of superoxide anion generated in KB-Ch R -8-5 measured as NBT reduction and expressed as μ moles of diformazan formed in vitro. All values are Mean ± SD. * P < 0.05 compared to control.

Figure 13
Figure 13

Effect of various n-6 and n-3 fatty acids on the amount of hydrogen peroxide generated in KB-Ch R -8-5 in vitro. All values are Mean ± SD. * P < 0.05 compared to control.

Figure 14
Figure 14

Effect of different doses of n-6 and n-3 fatty acids on the formation of lipid peroxides (expressed as pmoles of MDA-eq formed) in KB-Ch R -8-5 cells in vitro. All values are Mean ± SD. * P < 0.05 compared to control.

It is interesting to note that NBT reduction reaction (that detects superoxide anion generation) induced by fatty acids could be completely blocked by SOD suggesting that under the conditions employed, what is being measured, in fact, is the superoxide anion radical. The involvement of free radicals and lipid peroxides in the fatty acid-induced cytotoxicity is supported by the observation that both free radical generation and the formation of lipid peroxidation products (measured as MDA-reactive material) in KB-3-1 cells can be completely inhibited by vitamin E and SOD. This experiment was performed with 40 μg/ml of GLA, EPA and DHA fatty acids in KB-3-1 cells and the results are given in Figure 15.
Figure 15
Figure 15

Effect of anti-oxidants vitamin E and SOD (superoxide dismutase) on the generation of free radicals (superoxide anion) and lipid peroxides induced by GLA, EPA and DHA in KB-3-1 cells in vitro on day 3 of incubation with fatty acids. Superoxide anion generated in KB-3-1 cells was measured as NBT reduction (expressed as μ moles of diformazan formed) and lipid peroxides formed is measured by TBA reaction and expressed as pmoles of MDA-eq formed. All studies were done on day 3 following incubation with 40 μg/ml of fatty acids with or without vitamin E or SOD. All values are Mean ± SD. * P < 0.05 compared to control; #P < 0.05 compared to fatty acid treatment.

Uptake and efflux of radiolabeled vincristine in KB-3-1 and KB-ChR-8-5 cells in vitro

In order to understand the mechanism as to why KB-3-1 cells are sensitive whereas KB-ChR-8-5 cells are resistant to the cytotoxic action of vincristine, the uptake and efflux of radiolabeled vincristine in these cells was studied. The results shown in Figure 16 revealed that the uptake of vincristine is almost 4 to 5-fold higher in KB-3-1 cells compared with the uptake by KB-ChR-8-5 cells. On the other hand, the efflux of vincristine is 1 1/2 to 3 times less in KB-3-1 cells compared with the efflux shown by KB-ChR-8-5 cells. This difference in the uptake and efflux ultimately resulted in 2-3 fold higher concentration of vincristine in KB-3-1 cells compared to KB-ChR-8-5 cells. This higher intracellular concentration of vincristine in KB-3-1 cells could be responsible for their sensitivity to the cytotoxic action of vincristine, whereas KB-ChR-8-5 cell are resistant to the cytotoxic action of vincristine since they are able to effectively reduce the intracellular concentration of vincristine by an effective efflux pump. Thus, the uptake of vincristine is high in KB-3-1 cells and the efflux of the drug is minimal while vincristine- resistant KB-ChR-8-5 cells showed minimal uptake and very effective efflux mechanism to remove vincristine from within the cell. As a result, the accumulation of vincristine is not seen in resistant cells KB-ChR-8-5 cells.
Figure 16
Figure 16

Uptake and efflux of vincristine (radiolabeled) by vincristine-sensitive (KB-3-1) and vincristine-resistant (KB-Ch R -8-5) tumor cells in vitro at different time intervals.

Since, cell membrane properties determine the uptake and efflux of drugs, it is expected that supplementation of PUFAs that get incorporated into the cell membrane lipids to vincristine-resistant cells may render them sensitive to the cytotoxic action of vincristine by enhancing its uptake and reducing the efflux. Studies performed to verify this possibility showed that this is indeed the case as presented below.

Uptake and efflux of [3H] vincristine by KB-3-1 and KB-ChR-8-5 cells in the presence of various fatty acids

Effect of various n-6 fatty acids

Studies with LA
In the presence of various n-6 fatty acids such as LA, GLA, DGLA and AA the uptake and efflux of radiolabeled vincristine was substantially altered. When KB-3-1 cells were incubated for different time intervals with LA there was no significant change in the uptake and efflux of vincristine as shown in Figure 17. Both uptake and efflux of vincristine by KB-3-1 cells were almost similar that resulted in no significant increase in accumulation of vincristine in the cells. This suggests that LA is unlikely to enhance the cytotoxic action of vincristine when both are added together to the tumor cells. In a similar fashion, LA did not substantially enhance the accumulation of vincristine in drug-resistant cells KB-ChR-8-5 cells since both the uptake and efflux of vincristine were almost similar (see Figure 17).
Figure 17
Figure 17

Uptake and efflux of [ 3 H] vincristine by vincristine-sensitive (KB-3-1) and vincristine-resistant (KB-Ch R -8-5) tumor cells in vitro in the presence of LA. All values are shown as % of the control.

Studies with GLA
Unlike LA, GLA was effective in increasing the uptake of vincristine by 1.5 to 2-fold in both KB-31 and KB-ChR-8-5 cells as shown in Figure 18.
Figure 18
Figure 18

Uptake and efflux of [ 3 H] vincristine by vincristine-resistant (KB-Ch R -8-5) tumor cells in vitro in the presence of GLA. All values are expressed as % of control.

Studies with DGLA
Similar to GLA, DGLA was also effective in enhancing the uptake of vincristine and reducing the efflux resulting in enhanced intracellular concentration of the anti-cancer drug. But DGLA was definitely much less effective compared to GLA. The results of the studies done with DGLA are given in Figures 19. It may be noted that GLA is much more effective against KB-ChR-8-5 (vincristine-resistant cells) compared to DGLA in increasing the uptake of vincristine. Thus, GLA is more effective than DGLA both in enhancing the uptake of vincristine in KB-ChR-8-5 cells and reducing its efflux. This suggests that GLA may be more effective in sensitizing the vincristine-resistant cells to the cytotoxic action of vincristine compared to DGLA. Since both GLA and DGLA contain 3 double bonds (GLA = 18:3 while DGLA is 20:3), it appears as though the number of double bonds may not be responsible for this property (namely, uptake and efflux of vincristine by KB-ChR-8-5 cells) shown by the cells. It could be attributed to the number of carbon atoms.
Figure 19
Figure 19

Uptake and efflux of [ 3 H] vincristine by vincristine-sensitive (KB-3-1) tumor cells in vitro in the presence of DGLA. All values are expressed as % of control.

Studies with AA
It is seen from the results shown in Figure 20 that AA is more effective than GLA and DGLA in enhancing the uptake and decreasing the efflux of vincristine by both the vincristine-sensitive (KB-3-1) and vincristine-resistant (KB-ChR-8-5) cells. Since AA is more unsaturated and contain 20 carbon atoms (AA = 20:4), it appears as though both the chain length and unsaturation may contribute to the ability of the AA in enhancing the vincristine drug uptake and decrease in its efflux (vincristine) by tumor cells that could result in higher intracellular concentration(s) of the anti-cancer drug in drug-sensitive and drug-resistant cancer cells.
Figure 20
Figure 20

Uptake and efflux of [ 3 H] vincristine by vincristine-sensitive (KB-3-1) tumor cells in vitro in the presence of AA. All values are expressed as % of control.

Effect of various n-3 fatty acids

Studies with ALA
Similar studies were also performed with n-3 fatty acids: ALA, EPA and DHA. It is evident from these results shown in Figures 21, 22 and 23 that similar to LA, ALA is not effective in enhancing the uptake and decreasing the efflux of vincristine by KB-3-1 and KB-ChR-8-5 cells; whereas EPA (n-3, 20:5) and DHA (n-3, 22:6) significantly enhanced uptake and decreased efflux of vincristine by KB-3-1 and KB-ChR-8-5 cells such that the intracellular concentrations of the anti-cancer drug is increased leading to death of the tumor cells. Of all the three n-3 fatty acids tested DHA is the most effective followed by EPA while ALA is the least effective or has no effect (DHA > EPA > ALA). In addition both n-6 and n-3 fatty acids were more effective at higher concentrations (say 20 and 40 μg) while they were less effective at lower doses (5-10 μg). In general, GLA, AA, EPA and DHA were more effective in enhancing the uptake of vincristine but had a small effect in decreasing the efflux of the drug both in the KB-3-1 and KB-ChR-8-5 cells. This suggests that GLA, AA, EPA and DHA are more effective in enhancing the uptake of the anti-cancer drugs and had less effect in decreasing the efflux of the drugs. Nevertheless, GLA, AA, EPA and DHA effectively increased intracellular concentration of vincristine, an action that seems to be responsible for the augmentation of the cytotoxic action of anti-cancer drugs by PUFAs.
Figure 21
Figure 21

Uptake and efflux of [ 3 H] vincristine by vincristine-sensitive (KB-3-1) and vincristine-resistant (KB-Ch R -8-5) tumor cells in vitro in the presence of ALA. All values are % of control.

Figure 22
Figure 22

Uptake and efflux of [ 3 H] vincristine by vincristine-sensitive (KB-3-1) vincristine-resistant (KB-Ch R -8-5) tumor cells in vitro in the presence of EPA. All values are % of control.

Figure 23
Figure 23

Uptake and efflux of [ 3 H] vincristine by vincristine-sensitive (KB-3-1) vincristine-resistant (KB-Ch R -8-5) tumor cells in vitro in the presence of DHA. All values are % of control.

Effect of combined action of sub-optimal concentrations of vincristine and sub-optimal doses of PUFAs on KB-ChR-8-5 cells in vitro

If it is true that fatty acids are able to enhance the uptake and decrease the efflux of anti-cancer drugs, then it is anticipated that a combination of sub-optimal doses of anti-cancer drugs and sub-optimal doses of fatty acids could induce substantial cytotoxic action on tumor cells. Hence, studies were performed on the cytotoxic action of a combination of sub-optimal doses of vincristine and sub-optimal doses of fatty acids on their cytotoxic action on vincristine-resistant (KB-ChR-8-5) cells in vitro.

In this study, KB-ChR-8-5 (vincristine-resistant tumor) cells were exposed to sub-optimal doses of vincristine and sub-optimal doses of various n-6 and n-3 PUFAs. The results of these studies given in Figures 24, 25, 26, 27 and 28 showed that when KB-ChR-8-5 cells were exposed to 5 nm and 10 nm of vincristine and 5 μg and 10 μg of various fatty acids did not show any substantial increase in the number of dead cells compared to the control. Thus, 5 nm and 10 nm of vincristine and 5 μg and 10 μg of fatty acids when used alone could be considered as sub-optimal doses at which there is no increase in the number of dead cells in comparison to control.
Figure 24
Figure 24

Effect of sub-optimal doses of LA and GLA and vincristine on the proliferation of vincristine-resistant (KB-Ch R -8-5) tumor cells in vitro. All values are mean ± SE. In the study with sub-optimal doses of GLA, *P < 0.05 compared to control (vincristine 5 nm and 10 nm and GLA 5 μg/ml and 10 μg/ml).

Figure 25
Figure 25

Effect of sub-optimal doses of DGLA and AA and vincristine on the proliferation of vincristine-resistant (KB-Ch R -8-5) tumor cells in vitro. All values are expressed as Mean ± SE. *P < 0.05 compared to control (vincristine and DGLA and AA alone controls).

Figure 26
Figure 26

Effect of sub-optimal doses of ALA, EPA and vincristine on the proliferation of vincristine-resistant (KB-Ch R -8-5) tumor cells in vitro. All values are mean ± SE. *P < 0.05 compared to control.

Figure 27
Figure 27

Effect of sub-optimal doses of DHA and vincristine on the proliferation of vincristine-resistant (KB-Ch R -8-5) tumor cells in vitro. P < 0.05 compared to control.

Figure 28
Figure 28

Effect of sub-optimal doses of n-6 and n-3 fatty acids (10 μg of fatty acids) and vincristine (10 nm) on the proliferation of vincristine-resistant (KB-Ch R -8-5) tumor cells in vitro. * P < 0.05 compared to control.

On the other hand, when KB-ChR-8-5 cells were exposed to a combination of sub-optimal doses of vincristine and various n-6 and n-3 fatty acids, a significant increase in the number of dead cells was observed. Of all the fatty acids tested, GLA, DGLA, AA, EPA and DHA were found to be the most effective in enhancing the cytotoxicity of sub-optimal doses of vincristine. LA was found to the least effective whereas ALA was effective only to a limited extent in enhancing the cytotoxicity of sub-optimal doses of vincristine. These results suggest that a combination of sub-optimal doses of vincristine and GLA, DGLA, AA, EPA and DHA fatty acids are effective in substantially enhancing the death of vincristine-resistant (KB-ChR-8-5) tumor cells in vitro.

For easy understanding, a summary of the results obtained with sub-optimal doses of n-6 and n-6 fatty acids (10 μg of fatty acids) and vincristine (10 nm) is given in Figure 28.

It is evident from the results shown in Figures 24, 25, 26, 27 and 28 that there is a gradual enhancement in the cytotoxic action of sub-optimal doses of a combination of vincristine and fatty acids as given below:

Fatty acid 5 μg + Vincristine 5 nm < Fatty acid 10 μg + Vincristine 5 nm < Fatty acid 5 μg + Vincristine 10 nm < Fatty acid 10 μg + Vincristine 10 nm.

Thus, the most effective sub-optimal doses of vincristine and fatty acid in inducing the death of vincristine-resistant cells is vincristine 10 nm + fatty acid 10 μg. Of all the fatty acids tested, the most effective fatty acid is DHA. With regard to the fatty acids, the effectiveness of the fatty acids when used at sub-optimal doses in combination with vincristine is as follows: DHA > GLA > AA = EPA.

Uptake and efflux of fatty acids by vincristine-sensitive and vincristine-resistant cells in vitro

It is evident from the results shown in Figures 16, 17, 18, 19, 20, 21, 22 and 23 that the uptake and efflux of vincristine by vincristine-sensitive (KB-3-1) and vincristine-resistant (KB-ChR-8-5) cells is modified by various n-6 and n-3 fatty acids. GLA, AA, EPA and DHA enhanced the uptake of vincristine and reduced its efflux in these two cell lines. As a result, the intracellular concentration of vincristine is enhanced resulting in apoptosis of tumor cells. Thus, GLA, AA, EPA and DHA are capable of augmenting the apoptosis of both vincristine-sensitive and vincristine-resistant cells to vincristine. But, no data is available as to the uptake and efflux of fatty acids themselves in KB-3-1 and KB-ChR-8-5 cells. Hence, we studied the uptake and efflux of fatty acids in these two cell lines.

The results of this study given in Figures 29 and 30, suggest that the uptake of fatty acids is higher and the efflux is lower in KB-3-1 cells compared to the uptake and efflux of the same fatty acids in KB-ChR-8-5 cells. This could be one reason for the higher sensitivity of KB-3-1 cells to the cytotoxic action of fatty acids compared to KB-ChR-8-5 cells. Of the three fatty acids tested, the uptake and efflux of DHA = AA > ALA both in KB-3-1 and KB-ChR-8-5 cells.
Figure 29
Figure 29

Uptake and efflux of labeled fatty acids (ALA, AA, EPA) by vincristine-sensitive (KB-3-1) vincristine-resistant (KB-Ch R -8-5) cells in vitro at different time intervals.

Figure 30
Figure 30

A comparison of the uptake and efflux of fatty acids (ALA, AA, EPA) by vincristine-sensitive (KB-3-1) vincristine-resistant (KB-Ch R -8-5) cells in vitro at different time intervals.

Discussion

Previous studies showed that PUFAs such as GLA, AA, EPA and DHA have tumoricidal action (1-6, [31–36], for metabolism of essential fatty acids, EFAs, and see Figure 31). This tumoricidal action of fatty acids seems to depend on their ability to augment free radical generation and lipid peroxidation process in the tumour cells [1, 4, 5, 13, 25]. The involvement of free radicals is supported by the observation that antioxidants such as vitamin E, superoxide dismutase (SOD) and to some extent BHA and BHT (butylated hydroxy anisole and butylated hydroxytoluene, respectively) can prevent the tumoricidal action of PUFAs [1, 4, 13 and the present study]. Both free radicals and lipid peroxides induce damage to a variety of enzymes, proteins and DNA and thus, lead to cell death [37]. Further free radicals deplete ATP levels in the cells and cause apoptosis [38–40]. Since PUFAs enhance free radical generation and lipid peroxidation process and thus, induce apoptosis, it suggests that these events lead to depletion of ATP levels in the tumor cells which leads to their death. This implies that an interaction exists among fatty acids, lipid peroxidation process, apoptosis and genes/oncogenes that regulate apoptotic process [12].
Figure 31
Figure 31

Metabolism of essential fatty acids.

In this context, it is important to note that reactive oxygen metabolite hydrogen peroxide (H2O2) stimulates AA release and thromboxane A2 (TXA2) synthesis in the rat alveolar macrophage, but does not stimulate 5-lipoxygenase metabolism to form leukotriene B4 (LTB4), LTC4, or 5-hydroxyeicosatetraenoic acid (5-HETE). H2O2 dose-dependently inhibited synthesis of LTB4, LTC4, and 5-HETE induced by the agonists A23187 (10 microM) and zymosan (100 micrograms/ml), over the same concentration range at which it augmented synthesis of the cyclooxygenase products TXA2 and 12-hydroxy-5,8,10-heptadecatrienoic acid. This action of H2O2 on 5-lipoxygenase and cyclo-oxygenase synthesis is due to the ability of H2 O2 to deplete cellular ATP, a cofactor for 5-lipoxygenase. Thus, H2O2 can act both as an agonist for macrophage AA metabolism, and as a selective inhibitor of the 5-lipoxygenase pathway by its ability to deplete ATP [40]. These results are interesting in the light of the observation that LTs enhance the growth of tumor cells [41, 42]. This can be interpreted to mean that free radicals, especially H2O2, induce apoptosis of tumor cells by depleting the cells (a) of their ATP content, and (b) of LTs that are tumor growth promoters by selectively inhibiting 5-lipoxygenase activity [43, 44]. But, this growth inhibitory action of LTs is not without controversy since some studies did suggest that LTB4 and LTC4 may have tumor growth inhibitory actions [45, 46]. These controversial results could be due to the differences tumor cell lines studied and the doses of LTs employed.

In the light of these evidences, the result of the present study wherein it is noted that GLA, AA, EPA and DHA are cytotoxic to both vincristine-sensitive and resistant tumor cells is interesting. The inability of both indomethacin and NDGA, a CO and LO inhibitors respectively, to block, while the ability of vitamin E and SOD to completely inhibit the cytotoxic action of GLA and DHA on KB-3-1 cells suggested that in all probability PGs, LTs and TXs do not participate in the cytotoxic action of PUFAs. It is possible that KB-3-1 cells and possibly. KB-ChR-8-5 cells do not form significant amounts of LTs that are known to enhance the growth of tumor cells [41, 42]. The failure of calmodulin antagonists: chlorpromazine (CPZ) and trifluoperazine (TFP) to block the cytotoxic action of PUFAs indicates that calmodulin does not play a role in the proliferation of KB-3-1 and KB-ChR-8-5 cells. Though antioxidant vitamin E completely blocked the cytotoxic action of PUFAs (GLA, AA, EPA and DHA), failure of BHA and BHT, synthetic antioxidants, to show similar inhibitory action is rather surprising. This may mean that the free radicals that are scavenged by vitamin E and BHA and BHT are different and/or act on the free radical-mediated cellular processes in vastly different manner(s). Both mannitol and catalase were partially effective in inhibiting the GLA- and DHA-induced cytotoxicity (Figure 8) suggesting that there is only partial involvement of hydroxyl radical and H2O2 respectively in their cytotoxic action [47]. On the other hand, vitamin E completely blocked the cytotoxic actions of GLA, AA, EPA and DHA on both vincristine-sensitive and resistant cells by suppressing free radical generation in these cells (Figure 15). The ability of vitamin E but not of synthetic antioxidants BHA and BHT and only partial inhibition by catalase and mannitol suggests that, perhaps, all types of free radicals (superoxide anion, H2O2, hydroxyl radicals) and lipid peroxides play a role in the induction of apoptosis of tumor cells by PUFAs. The potent action of vitamin E in the inhibition of PUFA-induced tumoricidal action could also be attributed to its lipid soluble nature, its ability to protect glutathione against microsomal lipid peroxidation [48] and block lipid peroxidation chain reaction [49]. As a result of these actions, vitamin E is able to remove free radical intermediates and prevent the oxidation reaction from continuing. This is supported by the observation that vitamin E prevented PUFA-induced free radical generation and formation of lipid peroxides in vincristine-sensitive cells (Figure 15).

Since drug-resistance is a major issue in clinical practice, we studied whether PUFAs have the ability to alter the sensitivity of vincristine-resistant cells to the cytotoxic action of vincristine in vitro. Based on the results obtained in the present study, it is clear that certain PUFAs are not only capable of selectively killing the tumor cells with little effect on normal cells at the concentrations tested but are also capable of enhancing the uptake of anti-cancer drugs both by drug-sensitive and drug-resistant tumor cells (see Figures 17, 18, 19, 20, 21, 22 and 23) and may reverse tumor cell drug resistance in vitro. Thus, GLA, AA, EPA and DHA are able to bring about their tumoricidal action (i) by enhancing free radical generation and lipid peroxidation process in tumor cells and (ii) by increasing intracellular concentration of the anti-cancer drugs.

These results are further supported by the observation that when sub-optimal doses of vincristine and PUFAs are used, the cytotoxic action of vincristine was substantially enhanced especially by GLA, DGLA, AA, EPA and DHA (Figures 24, 25, 26, 27 and 28). In addition, uptake of PUFAs is higher in vincristine-sensitive cells compared to vincristine-resistance cells while the efflux is higher in the vincristine-resistant cells compared with vincristine-sensitive cells (Figures 29 and 30). These results indicate that, in general, drug-resistant cells show higher efflux compared to drug-sensitive tumor cells not only to anti-cancer drugs but also to PUFAs whereas drug-sensitive cells show higher uptake and decreased efflux to anti-cancer drugs and PUFAs (Figures 17, 18, 19, 20, 21, 22 and 23 and Figures 29 and 30). These studies imply that PUFAs could be used to reduce drug-resistance or reverse drug-resistance by various tumor cells such that chemotherapeutic drugs could bring about their tumoricidal action more effectively.

Previous studies [1–5, 11, 14] suggested that PUFAs (if not all at least GLA, AA, EPA and DHA) have differential toxicity towards normal and tumor cells indicating that normal and tumor cells metabolize fatty acids differentially. For instance, AA is metabolized to produce the 5-lipoxygenase metabolite, 5-HETE (5-hydroxyeicosatetraenoic acid) by prostate cancer cells that stimulated their growth, suggesting that 5-HETE is a survival factor for these cells. Prostate cancer cells constitutively produce 5-HETE and exogenous arachidonate markedly increases the production of 5-HETE, while inhibition of 5-lipoxygenase induced apoptosis in both hormone-responsive (LNCaP) and -nonresponsive (PC3) human prostate cancer cells. Apoptosis was specific for 5-lipoxygenase-programmed cell death since it was not observed with inhibitors of 12-lipoxygenase, cyclooxygenase, or cytochrome P450 pathways of AA metabolism. Exogenous 5-HETE protected these cells from apoptosis induced by 5-lipoxygenase inhibitors, confirming a critical role of 5-lipoxygenase activity in the survival of these cells [50]. Hence, it can be said that the way free fatty acids are metabolized by tumor cells, be drug-sensitive and drug-resistant cells, influence survival and progression of cancer. For example, free AA and GLA are tumoricidal but when AA is converted to form 5-HETE by 5-lipoxygenase, the tumor cells are stimulated to grow [51, 52].

Cyclooxygenase-2 (COX-2) is up-regulated in many cancers that may explain as to why COX-2 inhibitors prevent colon cancer. This, in part, could be attributed to an accumulation of the substrate (AA) or diversion of the substrate into another pathway. For example, colon adenocarcinomas overexpress AA-utilizing enzyme, fatty acid-CoA ligase (FACL) 4, in addition to COX-2. Thus, unesterified arachidonic acid in cells is a signal for induction of apoptosis. Tumor cells engineered with inducible overexpression of COX-2 and FACL4 act as "sinks" for unesterified AA as evidenced by the observation that activation of the enzymatic sinks blocked apoptosis, and the reduction of cell death was inversely correlated with the cellular level of AA. Cell death caused by TNF-α is prevented by removal of unesterified AA, suggesting that cellular level of unesterified AA and other unsaturated fatty acids is a general mechanism by which apoptosis is regulated and that COX-2 and FACL4 promote carcinogenesis by lowering this level [53–56]. Furthermore, NSAIDs up-regulated 15-LOX-1 and 15-LOX-1 inhibition blocked NSAID-induced apoptosis, which was restored by 13-S-HODE (13-S-hydroxyoctadecadienoic acid, is the product of 15-LOX-1 protein, the other product of 15-LOX-1 is 15-S-HETE, but in this study 15-S-HETE formation was not noted) but not by its parent, LA. Thus, NSAIDs induce apoptosis in colon cancer cells via up-regulation of 15-LOX-1 in the absence of COX-2 [57–59]. Hydroperoxides generated by 5-, 12-, or 15-lipoxygenases from linoleate, linolenate, or arachidonate (hydroperoxides may be detected as lipid peroxides by MDA reaction as was done in the present study), and the corresponding hydroxides induced apoptosis of erythroleukemia and neuroblastoma cells in a concentration- and time-dependent manner, while the terminal products of the arachidonate cascade (i.e., leukotrienes, prostaglandins and thromboxanes) were not cytotoxic [60]. These results are supported by the results of the present study wherein it is noted that both CO and LO inhibitors did not block the cytotoxic action of PUFAs. Thus, free unsaturated fatty acids need to be converted to their respective hydroxides to bring about their tumoricidal action. In addition, many AA metabolites serve as growth signaling molecules. 5-lipoxygenase (5-LO) pathway metabolite 5(S)-hydrooxyeicosa-6E,8C,11Z,14Z-tetraenoic acid (5-HETE) has a growth stimulatory action on breast cancer cells whereas selective reduction in the levels of 5-HETE but not cyclooxygenase inhibitors reduced growth, increased apoptosis, down-regulated bcl-2, up-regulated bax, and increased G1 arrest. 5-LO inhibition up-regulated peroxisome proliferator-activated receptor-α (PPAR-α) and PPAR-γ expression, and were growth inhibited when exposed to relevant PPAR agonists. These results suggest that disruption of the 5-LO signaling pathway mediates growth arrest and apoptosis in breast cancer cells, partly, by the induction of PPARs and activation of PPARs with shunted endoperoxides [61, 62]. These results imply that delivery of free unsaturated fatty acids to the tumor cells and generation of hydroperoxides by 5- 12-, or 15-lipoxygenases from various PUFAs such as AA, and simultaneous inhibition of COX-2 enzyme could lead to apoptosis of tumor cells. In addition, PUFAs suppress fatty acid synthase enzyme and thus, induce apoptosis of tumor cells [63–69].

Based on the preceding discussion, one intriguing possibility is that PUFAs are differentially metabolized by normal and tumor cells and drug-sensitive and drug-resistant cells (in addition to the differential uptake and efflux shown by the drug resistant tumor cells). This is so because PUFAs form precursors to both cytotoxic and cytoprotective molecules. For instance, as discussed above, generation of hydroperoxides by 5- 12-, or 15-lipoxygenases from linoleate, linolenate, or AA have cytotoxic actions and induce apoptosis of tumor cells. In contrast, lipoxins, resolvins, and protectins (including neuroprotectin D1) have cytoprotective properties by virtue of their anti-inflammatory actions. Thus, it is likely that when tumor cells are exposed to adequate amounts of PUFAs cytotoxic metabolites are generated that induce apoptosis of tumor cells, whereas normal cells convert PUFAs to cytoprotective molecules such as lipoxins, resolvins and protectins [70–81]. This is supported by the observation that DHA is toxic to tumor cells but protects normal neural cells from stress-induced apoptosis and is less or not cytotoxic to normal cells [1, 3, 11]. DHA induces apoptosis of neuroblastoma cells due to its conversion to 17-hydroxydocosahexaenoic acid (17-HDHA) via 17-hydroperoxydocosahexaenoic acid (17-HpDHA) through 15-lipoxygenase and autoxidation [82] and as a result tumor cells do not produce (or form negligible amounts) of the anti-inflammatory lipid mediators such as resolvins and protectins. 17-HpDHA is cytotoxic to tumor cells [70] and DHA itself could inhibit secretion of PGE2. Thus, the cytotoxic action of DHA on neuroblastoma and other tumor cells could be due to the production of hydroperoxy fatty acids and restricted production of resolvins and protectins that are cytoprotective in nature [83–86]. In a similar fashion, it is possible that when normal cells are exposed to GLA, AA, and EPA significant amounts of lipoxins and resolvin and other similar compounds are formed, whereas tumor cells would accumulate respective, prostanoids, leukotrienes, thromboxanes and cyclopentanone prostaglandins and respective hydroperoxy fatty acids that are toxic. Hence, it is proposed that normal cells metabolize PUFAs to produce cytoprotective lipids such as lipoxins, resolvins and protectins while tumor cells generate toxic hydroperoxy fatty acids [87]. This differential metabolism of PUFAs by normal and tumor cells may explain why PUFAs are toxic to tumor but not to normal cells (see Figure 32). The fact that both CO and LO inhibitors did not inhibit the cytotoxic action of PUFAs while there is an increase in the formation of lipid peroxides in the tumor cells suggests that products other than PGs, LTs and TXs such as hydroperoxides (similar to 17-HpDHA) are formed that induce tumor cell death. In view of this, it would have been interesting had we measured various hydroperoxides, lipoxins, resolvins and protectins that are formed in tumor cells in the present study. In future, such studies need to be performed to confirm the proposals made above.
Figure 32
Figure 32

Scheme showing the differential metabolism of PUFAs in normal and tumor cells. Normal cells exposed to anti-cancer drugs and radiation produce increased amounts of ROS. In response to this, normal cells produce enhanced amounts of lipoxins, resolvins and protectins from PUFAs that are released by the activation of phospholipase A2. Infiltrating or local leukocytes and macrophages produce enhanced amounts of IL-6 and TNF-α that, in turn, enhance ROS generation and cause inflammation. If cell stores of PUFAs are adequate, activation of phospholipase A2 (the type of phospholipase activated in normal and tumor cells may be distinctly different) leads to release of PUFAs to be converted to lipoxins, resolvins and protectins, which suppress leukocyte and macrophage activation, ROS generation and inflammation to protect normal cells from apoptosis. In the case of tumor cells, infiltrating leukocytes and macrophages produce enhanced amounts of IL-6 and TNF-α that produce excess amounts of ROS leading to inflammation. ROS damage DNA and aid in the progression of cancer. Tumor cells have decreased amounts of PUFAs that get are converted to pro-inflammatory eicosanoids due to activation of COX-2 and LO and thus, inflammation and cancer growth are perpetuated. Normal cells supplemented with PUFAs produce adequate amounts of lipoxins, resolvins and protectins that protect them from ROS, suppress inflammation and prevent actions of mutagens and carcinogens. On the other hand, tumor cells supplemented with PUFAs generate more free radicals, show enhanced lipid peroxidation that lead to apoptosis. Thus, normal cells exposed to PUFAs produce cytoprotective lipoxins, resolvins and protectins while tumor cells generate toxic hydroperoxy fatty acids.

In summary, results of the present study and previous reports [1–17] indicate that
  1. (i)

    free PUFAs and their hydroperoxides are toxic to tumor cells;

     
  2. (ii)

    PUFAs- induced tumoricidal action could be attributed to their ability to enhance free radical generation and lipid peroxidation process;

     
  3. (iii)

    PUFAs augment uptake and decrease efflux of anti-cancer drugs and thus, reverse tumor cell drug resistance;

     
  4. (iv)

    Tumor cells have an effective efflux mechanism to overcome the cytotoxic action of anti-cancer drugs;

     
  5. (v)

    CO and LO metabolites of PUFAs are less toxic to tumor cells compared to their (PUFAs) peroxides (measured in the present as total lipid peroxides) such as hydroperoxides (82);

     
  6. (vi)

    Enhanced activity of CO and LO enzymes in tumor cells may serve as an escape mechanism to overcome tumoricidal action of free PUFAs;

     
  7. (vii)

    A combination of PUFAs and anti-cancer drugs show enhanced cytotoxicity against tumor cells;

     
  8. (viii)

    Normal cells may form enhanced amounts of cytoprotective molecules such as lipoxins, resolvins and protectins while tumor cells form cytotoxic lipid hydroperoxides and other peroxides (a concept that needs further confirmation); and

     
  9. (ix)

    Tumor cell drug resistance could be due to increased formation of cytoprotective molecules such as lipoxins, resolvins and protectins, a concept that needs to be confirmed by further studies (see Figure 32).

     

Declarations

Acknowledgements

Dr. U N Das is in receipt of Ramalingaswami Fellowship from the Department of Biotechnology, India during the tenure of this study. This work is supported by financial assistance from DRDO (Defence Research and development Organisation), India to UND.

Authors’ Affiliations

(1)
Jawaharlal Nehru Technological University, Kakinada, 533 003, India
(2)
UND Life Sciences, 13800 Fairhill Road, #321, Shaker Heights, OH 44120, USA
(3)
Bio-Science Research Centre, Gayatri Vidya Parishad College of Engineering, Visakhapatnam, 530 048, India

References

  1. Das UN: Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Lett. 1991, 56: 235-243. 10.1016/0304-3835(91)90008-6View ArticlePubMedGoogle Scholar
  2. Sangeetha P, Das UN: Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells in vitro. Prostaglandins Leukot Essen Fatty Acids. 1995, 53: 287-299. 10.1016/0952-3278(95)90129-9.View ArticleGoogle Scholar
  3. Begin ME, Ell G, Das UN, Horrobin DF: Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst. 1986, 77: 1053-1062.PubMedGoogle Scholar
  4. Sagar PS, Das UN, Koratkar R, Ramesh G, Padma M, Kumar GS: Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells: Relationship to free radicals, and lipid peroxidation and its modulation by calmodulin antagonists. Cancer Lett. 1992, 63: 189-198. 10.1016/0304-3835(92)90260-3View ArticlePubMedGoogle Scholar
  5. Kumar SG, Das UN: Free radical dependent suppression of mouse myeloma cells by alpha-linolenic and eicosapentaenoic acids in vitro. Cancer Lett. 1995, 92: 27-38. 10.1016/0304-3835(95)03753-JView ArticlePubMedGoogle Scholar
  6. Solomon LZ, Jennings AM, Hayes MC, Bass PS, Birch BR, Cooper AJ: Is gamma-linolenic acid an effective intravesical agent for superficial bladder cancer? In vitro cytotoxicity and in vivo tolerance studies. Urol Res. 1998, 26: 11-15. 10.1007/s002400050016View ArticlePubMedGoogle Scholar
  7. Menéndez JA, Ropero S, del Barbacid MM, Montero S, Solanas M, Escrich E, Cortés-Funes H, Colomer R: Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells. Breast Cancer Res Treat. 2002, 72: 203-219. 10.1023/A:1014968415759View ArticlePubMedGoogle Scholar
  8. Kafrawy O, Zerouga M, Stillwell W, Jenski LJ: Docosahexaenoic acid in phosphatidylcholine mediates cytotoxicity more effectively than other omega-3 and omega-6 fatty acids. Cancer Lett. 1998, 132: 23-29. 10.1016/S0304-3835(98)00163-3View ArticlePubMedGoogle Scholar
  9. Ge H, Kong X, Shi L, Hou L, Liu Z, Li P: Gamma-linolenic acid induces apoptosis and lipid peroxidation in human chronic myelogenous leukemia K562 cells. Cell Biol Int. 2009, 33: 402-410. 10.1016/j.cellbi.2009.01.014View ArticlePubMedGoogle Scholar
  10. Toit-Kohn JL, Louw L, Engelbrecht AM: Docosahexaenoic acid induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and p38 MAPK pathways. J Nutr Biochem. 2009, 20: 106-114. 10.1016/j.jnutbio.2007.12.005View ArticlePubMedGoogle Scholar
  11. Begin ME, Das UN, Ells G: Cytotoxic effects of essential fatty acids (EFA) in mixed cultures of normal and malignant human cells. Prog Lipid Res. 1986, 25: 573-576.View ArticleGoogle Scholar
  12. Das UN: Essential fatty acids, lipid peroxidation and apoptosis. Prostaglandins Leukot Essen Fatty Acids. 1999, 61: 157-163. 10.1054/plef.1999.0085.View ArticleGoogle Scholar
  13. Das UN, Begin ME, Ells G, Huang YS, Horrobin DF: Polyunsaturated fatty acids augment free radical generation in tumor cells in vitro. Biochem Biophys Res Commun. 1987, 145: 15-24. 10.1016/0006-291X(87)91281-2View ArticlePubMedGoogle Scholar
  14. Das UN, Huang YS, Begin ME, Ells G, Horrobin DF: Uptake and distribution of cis-unsaturated fatty acids and their effect on free radical generation in normal and tumor cells in vitro. Free Rad Biol Med. 1987, 3: 9-14. 10.1016/0891-5849(87)90033-5View ArticlePubMedGoogle Scholar
  15. Madhavi N, Das UN: Effect of n-6 and n-3 fatty acids on the survival of vincristine sensitive and resistant cervical carcinoma cells in vitro. Cancer Lett. 1994, 84: 31-41. 10.1016/0304-3835(94)90355-7View ArticlePubMedGoogle Scholar
  16. Sangeetha P, Das UN: Gamma-linolenic acid and eicosapentaenoic acid potentiate the cytotoxicity of anti-cancer drugs on human cervical carcinoma (HeLa) cells in vitro. Med Sci Res. 1993, 21: 457-459.Google Scholar
  17. Menendez JA, Ropero S, del Barbacid MM: Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells. Breast Cancer Res Treat. 2002, 72: 203-219. 10.1023/A:1014968415759View ArticlePubMedGoogle Scholar
  18. Hernandez M, Bayon Y, Sanchez Crespo M, Nieto ML: Signaling mechanisms involved in the activation of arachidonic acid metabolism in human astrocytoma cells by tumor necrosis factor-alpha: phosphorylation of cytosolic phospholipase A2 and transactivation of cyclo-oxygenase-2. J Neurochem. 1999, 73: 1641-1649.View ArticlePubMedGoogle Scholar
  19. Rudra PK, Krokan HE: Cell-specific enhancement of doxorubicin toxicity in human tumour cells by docosahexaenoic acid. Anticancer Res. 2001, 21: 29-38.PubMedGoogle Scholar
  20. Akiyama S: Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet. 1985, 11: 117-126. 10.1007/BF01534700View ArticlePubMedGoogle Scholar
  21. Shen DW: Multiple drug-resistant human KS carcinoma cells independently selected for high level resistance to colchicine, adriamycin or vinblastine show changes in expression of specific proteins. J Biol Chem. 1986, 261: 7762-7770.PubMedGoogle Scholar
  22. Thimmaiah KN: Structural determinants of phenoxazine type compound required to modulate the accumulation vinblastine and vincristine in multidrug resistant cell lines. Cancer Commun. 1990, 2: 249-259.PubMedGoogle Scholar
  23. Das UN, Ells G, Begin ME, Horrobin DF: Free radicals as possible mediators of the actions of interferon. J Free Rad Biol Med. 1986, 2: 183-188. 10.1016/S0748-5514(86)80068-X.View ArticleGoogle Scholar
  24. Das UN: Stimulation of free radical generation in human leukocytes by various agents including tumor necrosis factor is a calmodulin dependent process. Biochem Biophys Res Commun. 1990, 167: 1030-1037. 10.1016/0006-291X(90)90626-XView ArticlePubMedGoogle Scholar
  25. Badway JA: Cis-unsaturated fatty acids induce high levels of superoxide production by human neutrophils. J Biol Chem. 1984, 256: 2640-12643.Google Scholar
  26. Kumar KV, Das UN: Are free radicals involved in the pathobiology of human essential hypertension?. Free Rad Res Commun. 1993, 19: 59-64. 10.3109/10715769309056499. 10.3109/10715769309056499View ArticleGoogle Scholar
  27. Pick E, Keisri Y: A simple colorimetric method for the measurement of H2O2 produced by cells in culture. J Immunol. 1980, 38: 161-170.Google Scholar
  28. Prabha PS, Das UN: Free radicals, lipid peroxidation and essential fatty acids in patients with septicemia. Prostaglandins Leukot Essen Fatty Acids. 1991, 42: 61-65. 10.1016/0952-3278(91)90068-G.View ArticleGoogle Scholar
  29. Bernheim S: The reaction between thiobarbituric acid and the oxidation products of certain lipids. J Biol Chem. 1948, 174: 257-264.PubMedGoogle Scholar
  30. Sangeetha P, Das UN: Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Rad Biol Med. 1990, 83: 15-20.View ArticleGoogle Scholar
  31. Leary WP, Robinson KM, Booyens J, Dippenar N: Some effect of gamma-linolenic acid on cultured human oesophageal carcinoma cells. S Afr Med J. 1984, 82: 681-683.Google Scholar
  32. Seigal I, Lin TL, Yaghoubzadch E, Kaskey TS, Greicher N: Cytotoxic effects of free fatty acids on ascites tumour cells. J Natl Cancer Inst. 1987, 78: 271-277.Google Scholar
  33. Chen Q, Gallenno M, Cederbaum AI: Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells over expressing human cytochrome p-4502E 1. Alcohol Clin Exp Res. 1998, 22: 782-784. 10.1111/j.1530-0277.1998.tb03868.xView ArticlePubMedGoogle Scholar
  34. Colquhoun A: Induction of apoptosis by polyunsaturated fatty acids and its relationship to fatty acid inhibition of carnitine palmitoyl transferase I activity in HepG2 cells. Bio Chem Mol Bio Int. 1998, 45: 331-336.Google Scholar
  35. Williams JR, Leaver HA, Ironside JW, Miller EP, Whittle IR, Gregor A: Apoptosis in human primary brain tumours. Actions of arachidonic acid. Prostaglandins Leukot Essent Fatty Acids. 1998, 58: 193-200. 10.1016/S0952-3278(98)90113-2View ArticlePubMedGoogle Scholar
  36. Tang DG, Guan KL, Li L: Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids. Int J Cancer. 1997, 72: 1078-1087. 10.1002/(SICI)1097-0215(19970917)72:6<1078::AID-IJC24>3.0.CO;2-#View ArticlePubMedGoogle Scholar
  37. Kumar SG, Das UN: Free radical dependent suppression of growth of mouse myeloma cells by alpha-linolenic and eicosapentaenoic acid in vitro. Cancer Lett. 1995, 92: 27-38. 10.1016/0304-3835(95)03753-JView ArticlePubMedGoogle Scholar
  38. Fernandes G, Chandra Sekhar B, Luan X, Troyer DA: Modulation of antioxidant enzymes and programmed cell death by n-3 fatty acids. Lipids. 1996, 31: 591-596.View ArticleGoogle Scholar
  39. Southgate J, Pitt E, Trejdoesiewicz LK: The Effects of dietary fatty acids on the proliferation of normal human urothelial cells in vitro. Br J Cancer. 1996, 74: 728-734. 10.1038/bjc.1996.429PubMed CentralView ArticlePubMedGoogle Scholar
  40. Sporn PH, Peters-Golden M: Hydrogen peroxide inhibits alveolar macrophage 5-lipoxygenase metabolism in association with depletion of ATP. J Biol Chem. 1988, 263: 14776-14783.PubMedGoogle Scholar
  41. Ishii K, Zaitsu M, Yonemitsu N, Kan Y, Hamasaki Y, Matsuo M: 5-lipoxygenase pathway promotes cell proliferation in human glioma cell lines. Clin Neuropathol. 2009, 28: 445-452.View ArticlePubMedGoogle Scholar
  42. Bachi AL, Kim FJ, Nonogaki S, Carneiro CR, Lopes JD, Jasiulionis MG, Correa M: Leukotriene B4 creates a favorable microenvironment for murine melanoma growth. Mol Cancer Res. 2009, 7: 1417-1424. 10.1158/1541-7786.MCR-09-0038View ArticlePubMedGoogle Scholar
  43. Ihara A, Wada K, Yoneda M, Fujisawa N, Takahashi H, Nakajima A: Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer. J Pharmacol Sci. 2007, 103: 24-32. 10.1254/jphs.FP0060651View ArticlePubMedGoogle Scholar
  44. Tong WG, Ding XZ, Talamonti MS, Bell RH, Adrian TE: LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochem Biophys Res Commun. 2005, 335: 949-956. 10.1016/j.bbrc.2005.07.166View ArticlePubMedGoogle Scholar
  45. Przylipiak A, Hafner J, Przylipiak J, Runnebaum B, Rabe T, Köhn FM: Influence of leukotrienes on in vitro growth of human mammary carcinoma cell line MCF-7. Eur J Obstet Gynecol Reprod Biol. 1998, 77: 61-65. 10.1016/S0301-2115(97)00217-0View ArticlePubMedGoogle Scholar
  46. Naidu KA, Wiranowska M, Phuphanich S, Prockop LD: Modulation of glioma cell growth and 5-lipoxygenase expression by interferon. Anticancer Res. 1996, 16: 3475-3482.PubMedGoogle Scholar
  47. Henderson BW, Miller AC: Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation. Radiat Res. 1986, 108: 196-205. 10.2307/3576825View ArticlePubMedGoogle Scholar
  48. Wefers H, Sies H: The protection of ascorbate and glutathione against microsomal lipid peroxidation is dependent on Vitamin E". Eur J Biochem. 1988, 174: 353-357. 10.1111/j.1432-1033.1988.tb14105.xView ArticlePubMedGoogle Scholar
  49. Traber AJ: Vitamin E, antioxidant and nothing more. Free Rad Biol Med. 2007, 43: 4-15. 10.1016/j.freeradbiomed.2007.03.024PubMed CentralView ArticlePubMedGoogle Scholar
  50. Ghosh J, Myers CE: Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci USA. 1998, 95: 13182-13187. 10.1073/pnas.95.22.13182PubMed CentralView ArticlePubMedGoogle Scholar
  51. Rizzo MT, Regazzi E, Garau D, Akard L, Dugan M, Boswell HS, Rizzoli V, Carlo-Stella C: Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells. Cancer Res. 1999, 59: 5047-5053.PubMedGoogle Scholar
  52. Wolf LA, Laster SM: Characterization of arachidonic acid-induced apoptosis. Cell Biochem Biophys. 1999, 30: 353-368. 10.1007/BF02738119View ArticlePubMedGoogle Scholar
  53. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM: Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA. 2000, 97: 11280-11285.PubMed CentralView ArticlePubMedGoogle Scholar
  54. Cao Y, Dave KB, Doan TP, Prescott SM: Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. Cancer Res. 2001, 61: 8429-8434.PubMedGoogle Scholar
  55. Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA: Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res. 2002, 62: 6323-6328.PubMedGoogle Scholar
  56. Tang X, Sun YJ, Half E, Kuo MT, Sinicrope F: Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Cancer Res. 2002, 62: 4903-4908.PubMedGoogle Scholar
  57. Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM: 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res. 2000, 60: 6846-6850.PubMedGoogle Scholar
  58. Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, Lippman SM: 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst. 2000, 92: 1136-1142. 10.1093/jnci/92.14.1136View ArticlePubMedGoogle Scholar
  59. Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM, Lippman SM: Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res. 2001, 61: 4879-4884.PubMedGoogle Scholar
  60. Maccarrone M, Ranalli M, Bellincampi L, Salucci ML, Sabatini S, Melino G, Finazzi-Agrò A: Activation of different lipoxygenase isozymes induces apoptosis in human erythroleukemia and neuroblastoma cells. Biochem Biophys Res Commun. 2000, 272: 345-350. 10.1006/bbrc.2000.2597View ArticlePubMedGoogle Scholar
  61. Avis I, Hong SH, Martinez A, Moody T, Choi YH, Trepel J, Das R, Jett M, Mulshine JL: Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J. 2001, 15: 2007-2009.PubMedGoogle Scholar
  62. Hong SH, Avis I, Vos MD, Martínez A, Treston AM, Mulshine JL: Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Cancer Res. 1999, 59: 2223-2228.PubMedGoogle Scholar
  63. Leaver HA, Bell HS, Rizzo MT, Ironside JW, Gregor A, Wharton SB, Whittle IR: Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma. Prostaglandins Leukot Essent Fatty Acids. 2002, 66: 19-29. 10.1054/plef.2001.0336View ArticlePubMedGoogle Scholar
  64. Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R: Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis. Int J Oncol. 2004, 24: 1369-1383.PubMedGoogle Scholar
  65. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R: Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Int J Oncol. 2004, 24: 591-608.PubMedGoogle Scholar
  66. Menendez JA, Colomer R, Lupu R: Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis. Med Hypotheses. 2005, 64: 337-341. 10.1016/j.mehy.2004.06.032View ArticlePubMedGoogle Scholar
  67. Menendez JA, Colomer R, Lupu R: Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?. Med Hypotheses. 2005, 64: 342-349. 10.1016/j.mehy.2004.07.022View ArticlePubMedGoogle Scholar
  68. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng S-W, Cravatt BF: Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell. 2010, 140: 49-61. 10.1016/j.cell.2009.11.027PubMed CentralView ArticlePubMedGoogle Scholar
  69. Levine L: Proteasome inhibitors: their effects on arachidonic acid release from cells in culture and arachidonic acid metabolism in rat liver cells. BMC Pharmacol. 2004, 4: 15- 10.1186/1471-2210-4-15PubMed CentralView ArticlePubMedGoogle Scholar
  70. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N, Ashe KH, Frautschy SA, Cole GM: Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron. 2004, 43: 633-645. 10.1016/j.neuron.2004.08.013PubMed CentralView ArticlePubMedGoogle Scholar
  71. Lukiw WJ, Cui J-G, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG: A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005, 115: 2774-2783. 10.1172/JCI25420PubMed CentralView ArticlePubMedGoogle Scholar
  72. Comba A, Maestri DM, Berra MA, Garcia CP, Das UN, Eynard AR, Pasqualini ME: Effect of ω-3 and ω-9 fatty acid rich oils on lipoxygenases and cyclooxygenases enzymes and on the growth of a mammary adenocarcinoma model. Lipids Health Dis. 2010, 9: 112- 10.1186/1476-511X-9-112PubMed CentralView ArticlePubMedGoogle Scholar
  73. Liu B, Maher RJ, Hannun YA, Porter AT, Honn KV: 12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha. J Natl Cancer Inst. 1994, 86: 1145-1151. 10.1093/jnci/86.15.1145View ArticlePubMedGoogle Scholar
  74. Ding XZ, Tong WG, Adrian TE: 12-lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation. Int J Cancer. 2001, 94: 630-636. 10.1002/ijc.1527View ArticlePubMedGoogle Scholar
  75. Chen GG, Xu H, Lee JF, Subramaniam M, Leung KL, Wang SH, Chan UP, Spelsberg TC: 15-hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor gamma-dependent pathway. Int J Cancer. 2003, 107: 837-843. 10.1002/ijc.11447View ArticlePubMedGoogle Scholar
  76. Najid A, Beneytout JL, Tixier M: Cytotoxicity of arachidonic acid and of its lipoxygenase metabolite 15-hydroperoxyeicosatetraenoic acid on human breast cancer MCF-7 cells in culture. Cancer Lett. 1989, 46: 137-141. 10.1016/0304-3835(89)90021-9View ArticlePubMedGoogle Scholar
  77. Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM, Lippman SM: The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci USA. 2003, 100: 9968-9973. 10.1073/pnas.1631086100PubMed CentralView ArticlePubMedGoogle Scholar
  78. Nixon JB, Kim KS, Lamb PW, Bottone FG, Eling TE: 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins Leukot Essent Fatty Acids. 2004, 70: 7-15. 10.1016/j.plefa.2003.06.001View ArticlePubMedGoogle Scholar
  79. Kim SJ: Lipoxins formation by rat basophilic leukemia (RBL-1) cells. Res Commun Chem Pathol Pharmacol. 1990, 68: 159-174.PubMedGoogle Scholar
  80. Stenke L, Edenius C, Samuelsson J, Lindgren JA: Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia. Blood. 1991, 78: 2989-2995.PubMedGoogle Scholar
  81. Chen Y, Hao H, He S, Cai L, Li Y, Hu S, Ye D, Hoidal J, Wu P, Chen X: Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Mol Cancer Ther. 2010, 9: 2164-2174. 10.1158/1535-7163.MCT-10-0173View ArticlePubMedGoogle Scholar
  82. Gleissman H, Yang R, Martinod K, Lindskog M, Serhan CN, Johnsen JI, Kogner P: Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates. FASEB J. 2010, 24: 906-915. 10.1096/fj.09-137919PubMed CentralView ArticlePubMedGoogle Scholar
  83. Serhan CN, Arita M, Hong S, Gotlinger K: Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids. 2004, 39: 1125-1132. 10.1007/s11745-004-1339-7View ArticlePubMedGoogle Scholar
  84. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL: Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 2002, 196: 1025-1037. 10.1084/jem.20020760PubMed CentralView ArticlePubMedGoogle Scholar
  85. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K: Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med. 2000, 192: 1197-1204. 10.1084/jem.192.8.1197PubMed CentralView ArticlePubMedGoogle Scholar
  86. Serhan CN, Takano T, Chiang N, Gronert K, Clish CB: Formation of endogenous "antiinflammatory" lipid mediators by transcellular biosynthesis. Lipoxins and aspirin-triggered lipoxins inhibit neutrophil recruitment and vascular permeability. Am J Respir Crit Care Med. 2000, 161 (2 Pt 2): S95-S101.View ArticlePubMedGoogle Scholar
  87. Das UN: Essential fatty acids enhance free radical generation and lipid peroxidation to induce apoptosis of tumor cells. Clin Lipidology. 2011, 6: 463-489. 10.2217/clp.11.34.View ArticleGoogle Scholar

Copyright

© Das and Madhavi; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

Lipids in Health and Disease

ISSN: 1476-511X